date,title,source
Oct-17-18,Novartis Q3 Earnings Preview,Benzinga
Oct-18-18,[$$] Novartis to Buy Cancer-Drug Maker Endocyte for $2.1 Billion,The Wall Street Journal
Oct-18-18,Endocyte's $2.1 Billion Deal Rewards Investors Who Stuck It Out,Bloomberg
Oct-18-18,Novartis to Buy Biopharmaceutical Company Endocyte for $2.1 Billion,GuruFocus.com
Oct-18-18,This tiny biotech spun a quick $2 billion from $12 million,MarketWatch
Oct-18-18,FDA snubs Novartis bid to repurpose inflammation drug for heart attacks,Reuters
Oct-18-18,Novartis Reports Positive Long-Term Data From Cosentyx Trials,Zacks
Oct-18-18,Novartis Gets Key Therapy -- For Almost 200 Times Its Last Price,Bloomberg
Oct-18-18,"Why Endocyte, Inc. Stock Is Soaring Today",Motley Fool
Oct-18-18,Novartis Secures Prostate Cancer Treatment With Endocyte Deal,TheStreet.com
Oct-18-18,Novartis To Buy Endocyte In $2.1B Deal,Benzinga
Oct-18-18,[$$] Novartis to Buy Cancer-Drug Maker Endocyte for $2.1 Billion,The Wall Street Journal
Oct-18-18,"The Daily Biotech Pulse: Novartis Buys Endocyte, Proteostasis Positive Cystic Fibrosis Trial, 2 IPOs",Benzinga
Oct-18-18,Endocyte stock pops 50% on $2.1 bln Novartis acquisition,MarketWatch
Oct-18-18,[$$] European Equities Market Talk Roundup,The Wall Street Journal
Oct-18-18,Novartis pushes deeper into nuclear medicine with $2.1 billion deal,Reuters
Oct-18-18,Novartis: 3Q Earnings Snapshot,Associated Press
Oct-18-18,Novartis pushes deeper into nuclear medicine with $2.1 bln deal,Reuters
Oct-18-18,[$$] European Corporate News Roundup,The Wall Street Journal
Oct-18-18,Endocyte Enters Into Agreement to be Acquired by Novartis for $24/Share,Benzinga
Oct-18-18,Novartis to buy cancer drugmaker Endocyte for $2.1 billion in cash,Reuters
Oct-18-18,Novartis to buy cancer drugmaker Endocyte for $2.1 billion in cash,Reuters
Oct-18-18,Novartis to buy cancer drugmaker Endocyte for $2.1 bln in cash,Reuters
Oct-18-18,"Novartis raises 2018 sales outlook as Entresto, Cosentyx accelerate",Reuters
Oct-18-18,Novartis to buy Endocyte for $2.1 billion in cash,Reuters
Oct-18-18,Novartis CEO: No fundamental changes to operations from B...,CNBC Videos
Oct-19-18,"The Daily Biotech Pulse: Novartis Positive Liver Drug Trials, Krytstal Prices Offering, LogicBio To Debut",Benzinga
Oct-19-18,Today's Research Reports on Trending Tickers: Pfizer and Novartis,ACCESSWIRE
Oct-19-18,This tiny biotech spun a quick $2 billion from $12 million,MarketWatch
Oct-22-18,"Novartis (NVS) Q3 Earnings In Line, Revenues Beat Estimates",Zacks
Oct-22-18,"BIIB, ALKS Q3 Earnings Due on Oct 23: What's in Store?",Zacks
Oct-22-18,This tiny biotech spun a quick $2 billion from $12 million,MarketWatch
Oct-23-18,"Biotech Stocks Earnings Lineup for Oct 24: VRTX, ALXN & SRPT",Zacks
Oct-25-18,"Bulls bet this financial name is set to bounce. Plus, the...",CNBC Videos
Oct-26-18,"Pharma Stock Roundup: MRK, BMY Q3 Earnings, Cancer Data Presentations at ESMO",Zacks
Oct-26-18,"The Daily Biotech Pulse: Gilead's Q2, Syndax Breast Cancer Drug Setback, Synergy Pharma On Brink Of Default",Benzinga
Oct-29-18,Drugmakers tout new medicines as eye disease battle intensifies,Reuters
Oct-29-18,"Novartis, Pfizer join forces on potentially lucrative fatty liver disease",Reuters
Oct-30-18,Aging Blockbusters Send Amgen Inc.'s Bottom Line Lower,Motley Fool
Oct-30-18,Incyte Corp (INCY) Q3 2018 Earnings Conference Call Transcript,Motley Fool
Oct-31-18,GlaxoSmithKline plc (GSK) Q3 Earnings Conference Call Transcript,Motley Fool
Oct-31-18,Premier Bay Area biotech developer tees up next major project,American City Business Journals
Oct-31-18,"Aduro (ADRO) Q3 Loss Narrower Than Expected, Revenues Lag",Zacks
Oct-31-18,FDA approves Novartis' copy of AbbVie bestseller Humira,Reuters
Oct-31-18,"Amgen (AMGN) Beats on Earnings & Sales in Q3, Raises View",Zacks
Oct-31-18,"Glaxo (GSK) Beats Earnings Estimates in Q3, Revenue In-line",Zacks
Nov-01-18,Gene therapy: CHOP unveils $75M manufacturing facility (Photos),American City Business Journals
Nov-02-18,Novartis abandons effort for U.S. approval of biosimilar rituximab,Reuters
Nov-02-18,Novartis data at ASH and SABCS show strength of pipeline and portfolio in hematology and oncology,PR Newswire
Nov-02-18,"Conatus' (CNAT) Q3 Loss In Line, Revenues Lag Estimates",Zacks
